With the exception of wartime, concerns about the supply chain have never in living memory been more pressing than they are today. Americans, long accustomed to quick, easy access to relatively low-priced goods, have been confronted with a unusually high number of out-of-stocks since the arrival of COVID-19 and, based on the number of container
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA), in coordination with the Center for Supply Chain Studies, announced the successful conclusion of an industry-wide pilot of an interoperable ‘authorized trading partner’ credentialing ecosystem to support the requirements of the federal traceability law, the Drug Supply Chain Security Act (DSCSA). Pilot participants, other industry members and
JACKSON, Ms. – Providence Health Technologies (PHT), and Hamacher Resource Group (HRG) have completed a six-month pilot study as part of Food and Drug Administration’s (FDA) DSCSA pilot project program. The pilot study focused on identifying the ability of small dispensers to comply with recent Drug Supply Chain Security Act (DSCSA) requirements. The study focused
HARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released the following statement regarding the Department of Health and Human Services’ (HHS) proposed rule permitting prescription drug importation: “As an industry that saves healthcare between $33 and $53 billion each year by ensuring the safety, reliability and efficiency of the supply chain, HDA and its pharmaceutical
ARLINGTON, Va. —Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policies: “HDA and the nation’s primary pharmaceutical distributors appreciate the Trump administration’s efforts
